— Know what they know.
Not Investment Advice

GXXY OTC

Galexxy Holdings, Inc.
1W: +0.0% 1M: -92.3% 3M: -92.3% YTD: -92.3% 1Y: -98.3% 3Y: -99.9% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 46 · $28431 mcap · 147M float · 0.0053% daily turnover · Short 48% of daily vol

Income Trends

Revenue
$118K -88.8% ▼
5Y CAGR: +423.2%
Gross Profit
-$18K -104.2% ▼
Operating Income
-$2M -27.7% ▼
Net Income
-$3M -122.1% ▼
EPS (Diluted)
$-0.01 -86.4% ▼
EBITDA
-$3M -97.4% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$20K$0$536K$1M$118K
YoY Growth+66103.2%-100.0%+0.0%+97.0%-88.8%
Cost of Revenue$20K$0$253K$627K$136K
Gross Profit$0$0$283K$429K-$18K
Gross Margin0.0%—52.8%40.6%-15.0%
R&D Expenses$0$0$0$0$0
SG&A Expenses$161K$743K$2M$2M$2M
Operating Expenses$161K$743K$2M$2M$2M
Operating Income-$161K-$743K-$1M-$2M-$2M
Operating Margin-806.3%—-273.8%-152.3%-1732.8%
Interest Expense$0$0$70K$0$0
Income Before Tax-$161K-$743K-$18M-$2M-$3M
Tax Expense$0$0$0$0$0
Net Income-$161K-$743K-$18M-$1M-$3M
Net Margin-806.2%—-3286.3%-127.2%-2517.5%
EPS (Diluted)$-0.00$-0.00$-0.09$-0.01$-0.01
EBITDA-$161K-$743K-$18M-$2M-$3M
Shares Outstanding54M191M202M229M270M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms